secwatch.observer — SEC 8-K summary
======================================

Issuer:     Structure Therapeutics Inc. (GPCR)
CIK:        0001888886
Form:       8-K
Filed at:   2023-07-06T23:59:59+00:00
Accession:  0001104659-23-078719
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Structure Therapeutics enters three facility leases in Shanghai and South San Francisco
--------------------------------------------------------------------------------

- Operations lease for ~22,500 sq ft in Shanghai; annual rent ~5.20M yuan (~$0.72M); term Jan 2024–Dec 2026.
- Lab lease for ~8,400 sq ft in Shanghai; annual rent ~1.99M–2.12M yuan (~$0.27–0.29M); term Feb 2024–Jan 2027.
- Sublease for ~11,800 sq ft in South San Francisco; annual rent ~$0.49M initial +3% annual; term Aug 2023–Aug 2027, with 4-month rent abatement.
- Leases support R&D operations in China and corporate headquarters in the US.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923078719/0001104659-23-078719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1888886/000110465923078719/tm2319105d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-078719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer